Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose rituximab plus prednisone in idiopathic autoimmune hemolytic anemia
2008-006713-25Phase 2Completed
- Sponsor
- Policlinico di Milano
- Start
- Jan 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab and prednisone in autoimmune haemolytic anaemia (AIHA), sponsored by Policlinico di Milano. Primary endpoints: Overall clinical response, Complete response and 1 more. Started Jan 2009; status: completed.
02
Drugs
rituximabprednisone
03
Conditions
autoimmune haemolytic anaemia (AIHA)
Beyond the preview
Go deeper on 2008-006713-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006713-25.